Global POC Diagnostics Market 2022-2028
The global poc diagnostics market is projected to rise by USD 22 billion by 2028, according to a new report by Gen Consulting Company. It is anticipated to expand at a CAGR of 10.1 percent during the forecast period.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global poc diagnostics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the poc diagnostics industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, product, end user, and region. The global market for poc diagnostics can be segmented by type: alcohol and drug abuse, blood gas electrolyte and metabolite (BGEM), cardiac markers, cholesterol, glucose monitoring, hemoglobin/hemostasis, infectious diseases, pregnancy and fertility, urine chemistry, others. The glucose monitoring segment held the largest share of the global poc diagnostics market in 2021 and is anticipated to hold its share during the forecast period. Poc diagnostics market is further segmented by product: hardware, software. Globally, the hardware segment made up the largest share of the poc diagnostics market. Based on end user, the poc diagnostics market is segmented into: hospitals and critical care centers, home care settings. The home care settings segment was the largest contributor to the global poc diagnostics market in 2021. On the basis of region, the poc diagnostics market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). North America is estimated to account for the largest share of the global poc diagnostics market.
By type:
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global poc diagnostics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the poc diagnostics industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, product, end user, and region. The global market for poc diagnostics can be segmented by type: alcohol and drug abuse, blood gas electrolyte and metabolite (BGEM), cardiac markers, cholesterol, glucose monitoring, hemoglobin/hemostasis, infectious diseases, pregnancy and fertility, urine chemistry, others. The glucose monitoring segment held the largest share of the global poc diagnostics market in 2021 and is anticipated to hold its share during the forecast period. Poc diagnostics market is further segmented by product: hardware, software. Globally, the hardware segment made up the largest share of the poc diagnostics market. Based on end user, the poc diagnostics market is segmented into: hospitals and critical care centers, home care settings. The home care settings segment was the largest contributor to the global poc diagnostics market in 2021. On the basis of region, the poc diagnostics market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). North America is estimated to account for the largest share of the global poc diagnostics market.
By type:
- alcohol and drug abuse
- blood gas electrolyte and metabolite (BGEM)
- cardiac markers
- cholesterol
- glucose monitoring
- hemoglobin/hemostasis
- infectious diseases
- pregnancy and fertility
- urine chemistry
- others
- hardware
- software
- hospitals and critical care centers
- home care settings
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global poc diagnostics market.
- To classify and forecast the global poc diagnostics market based on type, product, end user, region.
- To identify drivers and challenges for the global poc diagnostics market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global poc diagnostics market.
- To identify and analyze the profile of leading players operating in the global poc diagnostics market.
- Gain a reliable outlook of the global poc diagnostics market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY TYPE
Alcohol and drug abuse
Blood gas electrolyte and metabolite (BGEM)
Cardiac markers
Cholesterol
Glucose monitoring
Hemoglobin/hemostasis
Infectious diseases
Pregnancy and fertility
Urine chemistry
Others
PART 6. MARKET BREAKDOWN BY PRODUCT
Hardware
Software
PART 7. MARKET BREAKDOWN BY END USER
Hospitals and critical care centers
Home care settings
PART 8. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 9. KEY COMPANIES
Abaxis, Inc.
Abbott Laboratories
Becton, Dickinson, and Co.
Chembio Diagnostics, Inc.
Danaher Corp.
EKF Diagnostics Holdings plc
F. Hoffmann-La Roche AG
Koninklijke Philips N.V.
OraSure Technologies, Inc.
Quidel Corporation
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Werfen GmbH
Wipro Limited
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY TYPE
Alcohol and drug abuse
Blood gas electrolyte and metabolite (BGEM)
Cardiac markers
Cholesterol
Glucose monitoring
Hemoglobin/hemostasis
Infectious diseases
Pregnancy and fertility
Urine chemistry
Others
PART 6. MARKET BREAKDOWN BY PRODUCT
Hardware
Software
PART 7. MARKET BREAKDOWN BY END USER
Hospitals and critical care centers
Home care settings
PART 8. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 9. KEY COMPANIES
Abaxis, Inc.
Abbott Laboratories
Becton, Dickinson, and Co.
Chembio Diagnostics, Inc.
Danaher Corp.
EKF Diagnostics Holdings plc
F. Hoffmann-La Roche AG
Koninklijke Philips N.V.
OraSure Technologies, Inc.
Quidel Corporation
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Werfen GmbH
Wipro Limited
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
